Atlas Trials

Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer

Clinical trial NCT03180437 · COMPLETED

Trial details

NCT number
NCT03180437
Sponsor
Fuda Cancer Hospital, Guangzhou
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2017-06-15
Primary completion
2018-06-15
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.